The UK medical cannabis sector has spent seven years arguing for access. The next argument will be settled on outcomes,
A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for
In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study.
AFTER a lively first day of sessions focused on the future of the cannabis industry, the second day of Cannabis
PRESS RELEASE Key NHS cannabis project to kick off A key project developing a flexible health economics analysis tool to
LAST week saw the British Government reinstate its hardline position on drug policy, as Policing Minister Kit Malthouse announced new
We won’t spam you
